I generally do the driving in our household, and my wife is usually seated in the front passenger seat. I am confident when I drive, and I have a spotless driving record. However, my wife does not always appreciate these facts. As I skillfully negotiate the curvy roadways in our town, she has been known to frequently gasp and stomp the floorboards as if there were a brake on her side of the car. As she whiteknuckles the armrest, she assures me that it isn't her mistrust of my driving, it is the lack of control that she feels when I drive. Whether it is the feeling people have when watching their teenagers head out on a Friday night, when traveling on a plane in inclement weather, or when following the current politics of our country, this ''out of control'' feeling is uncomfortable for most. What does this have to do with science? Well, we should have a similar uneasy feeling when we read studies that lack relevant controls. Designing experiments with appropriate controls is critical to ensure the validity of results and to transfer confidence in those results.
Consider the following hypothetical study evaluating a new patch for Achilles tendon repair. In this example, patients seeking Achilles tendon repair were recruited to undergo surgery with the new patch to augment their torn tendon. Patient-reported outcomes were collected preoperatively and again at 1 and 2 years postoperatively. The results of this suppositional, prospective case series found that the patient-reported outcomes significantly improved after surgery without any serious adverse events. What does this hypothetical study tell us? It could demonstrate that the patch is safe, if the sample size was large enough, since there were no serious adverse events. However, from this descriptive study, one cannot conclude that the new patch technique is better than the current standard of Achilles tendon repair or that it performed better than nonoperative treatment. At best, this case series might inform us that a randomized controlled study of the patch is warranted. Although experimental design improvements could be made to strengthen a case series, such as prospective consecutive enrollment of patients coming through the clinic or the use of a historical control group to provide additional insight, the risk of bias remains high. 11 Bias refers to systematic error in the study results that promotes a deviation from the truth. 4 The relevant sources of bias that can be reduced by use of a proper control group include selection bias, information bias, and confounding bias. 12 ''Selection bias occurs when the selection of participants in one group results in a different outcome than the selection for the other group.'' 8 An example would be recruiting a control group that is more sedentary than the patients assigned to the treatment group. ''Information bias occurs when data are collected differently between two groups, leading to an error in the conclusion or the association.'' 8 For instance, information bias is likely present when a new treatment group is compared with a historical control group where the data methods were not specified sufficiently to confirm replication. With a historical control group, it is often unknown whether the measurement conditions and procedures were replicated between the experimental and historical control groups. Confounding bias is introduced ''when the observed result between exposure and disease differs from the truth because of the influence of the additional variables.'' 8 An example would be the influence of activity level on anterior cruciate ligament (ACL) injury risk, as age is a confounding variable with activity level. The impact of these 3 types of bias can be minimized with appropriate study design and the proper selection of control groups.
The goal of experimental design is to reduce bias and the effects of confounding factors. For studies evaluating the effects of treatment, this can often be achieved through use of a control group. A control group is ''a group used as a standard for comparison in a controlled experiment,'' 1 and it ''ensures that the changes in the dependent variable are due to changes in the independent variables and not due to chance.'' 11 The control group could be a matched population of uninjured patients, a matched population of patients who did not receive treatment (a placebo or sham procedure), or a matched population who received the standard of care for comparison with the experimental group. Most frequently, a control group is a group that is equivalent to the experimental group but receives no intervention (eg, placebo). The ideal control method to use is always dictated by the study question. For example, to determine whether outcomes of ACL reconstruction surgery were different from outcomes of nonoperative treatment, the optimal study design is a prospective randomized controlled trial. Until recently, 7, 13 only nonrandomized studies had been performed to address this question. 9 Although one could argue that the nonoperatively treated group served as a control for the nonrandomized studies, it was not a matched group and therefore was not equivalent to the surgical experimental group. Without randomization, selection bias would be present, because it is likely that more active patients would be enrolled in the surgical group and less active patients would be enrolled in the nonoperative group.
A matched control group that recapitulates the age, sex, and activity level of the experimental group could also minimize the impact of all 3 biases. A number of years ago, I was involved with the design of a randomized controlled trial evaluating the effects of initial graft tension during ACL reconstruction on outcomes, including cartilage health. 2 Patients were randomized to 2 graft tensioning protocols and followed for 7 years after surgery. Concurrently, an uninjured control group matched for age, sex, race, and activity was recruited for comparison, because the primary outcome was an assessment of cartilage. For this investigation, it was important to show changes in cartilage health following the ACL reconstruction procedures compared with an equivalent uninjured ACL-intact population. The contralateral control is not adequate due to the potential of cross-over effects. Use of the matched control group proved to be insightful, as it showed how some of the commonly used outcomes, such as the Knee injury and Osteoarthritis Outcome Score (KOOS), functional performance measures, and imaging markers of cartilage health of the uninjured population, change as a function of age. The matched control group also allowed us to put the postsurgical ACL and meniscal injury rates of the experimental groups into perspective, as these injuries were also present in the matched control population, although to a lesser extent.
Other types of control groups are worth mentioning. A negative control is a group in which no response is expected, whereas a positive control is a group in which a known response is expected. For example, when one is designing a preclinical animal study to contrast a new treatment for a ligament injury with the gold standard treatment, the use of 2 control groups would be ideal: 1 group in which a knee arthrotomy is performed without disruption of the ligament (a negative control group) and 1 group in which the ligament is cut and left untreated (a positive control group). The outcomes of these 2 control groups would thus bracket the range of potential outcomes between the 2 surgical groups being compared, in order to clarify the magnitude of the effect provided by the surgical treatments.
Another type of useful control group is an internal control group. In an internal control group, the measurements are taken at the beginning of a study and then used as baseline data for subsequent comparisons. This approach is commonly used in cadaveric studies in which the intact state is first measured and then the measurements are repeated once an injury is simulated and then after it is repaired. Although this enables a within-subject comparison, one must assume that the measurements are not affected by the integrity of the specimen in response to repeated testing, a form of information bias. For the cadaveric situation, it is possible that other tissues of the joint stretch out when the injured and repaired states are tested, and thus the overall function of the joint may no longer be comparable to normal.
It is not possible to retest the intact state at the end of the study, but the effects of bias could still be put into perspective by repeated testing of the injured condition once testing of the repaired condition has been completed.
Finally, historical control groups are frequently used to provide context. Although a historical control group can provide insight and cost savings, this type of control group is prone to all 3 kinds of bias, and results should be interpreted cautiously.
Experimental design with the appropriate selection of control groups is an important consideration when one is designing a study as well as reading the literature. The hypothetical case series described above is an example of a ''descriptive'' study, as it focuses on one group of subjects and has no control group. 11 Descriptive studies should not be used to compare groups or to make clinical recommendations. However, they are valuable to identify new variables of interest and/or to generate new research questions. Prospective cohort studies are commonly performed to evaluate changes in a group of patients over time. 6 They can be descriptive, to evaluate occurrences of outcomes over time, or they can be analytical, to analyze associations between predictors and outcomes. 6 However, cohort studies are observational and readily influenced by confounding variables.
The nested case-control study design enables the investigator to follow a cohort of patients and then make retrospective comparisons between those who exhibit a particular outcome and those who do not. Thus, the case-control study design maintains the advantages of a prospective cohort study, while the unaffected control within that population helps to reduce bias. 6 The randomized clinical trial is the hallmark design to reduce bias associated in a comparative study. For this design, patients are randomly assigned to 1 of 2 treatments (eg, to receive a novel intervention [the experimental group] or to receive the standard of care [the control group]) and are then followed over time. The randomized controlled trial reduces the impact of selection bias and information bias and helps distribute confounding variables equally between groups to alleviate confounding bias. The randomized controlled trial should have an adequate sample size, have minimal loss to follow-up, and, if possible, entail double-blinding to further minimize bias. The Centre for Evidence-Based Medicine at the University of Oxford has implemented a rating system on a scale of 5 (high bias; eg, expert opinion) to 1 (low bias; eg, large randomized controlled trial) to help quantify the risk of bias. 11 Most journals, including the American Journal of Sports Medicine, use rating systems such as this to aid the reader in putting the conclusions of the study in context. The use of control groups, which minimize bias, is critical to these rating systems.
In this issue, several articles provide excellent examples of the value of control groups. The first is a case series evaluating outcomes after repair of a partial proximal hamstring avulsion at midterm follow-up. 3 The authors determined that surgical repair of these avulsions led to successful functional outcomes, a high rate of return to professional activity, and a low complication rate at 6.5-year follow-up. Because the study had no control group and used a retrospective study design, it was designated a Level 4 study. The limitations of the study were clearly described by the authors: No preoperative scores were available for comparison (no internal control), and a nonoperative control was not included. Despite the potential biases, the study suggests that the patients have good outcomes and that a controlled study is warranted.
The second article is a matched case-control study (Level 3). 5 From a large cohort of patients with ACL reconstruction, cases and matched controls age 21 years or younger were identified to compare anatomic features (ie, tibial slopes) between those requiring revision surgery (the cases) and those who did not (the controls). The authors were not able to identify an association between revision surgery and tibial slopes between groups. For this study, the use of the control group was valuable for reducing selection bias, and the impact of confounding bias was minimized by matching controls to the cases within the cohort. The authors clearly described the limitations of this experimental design and noted that the design was not adequate to demonstrate causality.
The third study is a randomized controlled trial (Level 2) to determine whether injection of hyaluronic acid in marathon runners protects against early cartilage changes as determined by magnetic resonance imaging (MRI). 10 Runners were randomized to receive an injection of hyaluronic acid (the experimental group) or normal saline (the placebo control group). The injections were performed 1 week before participants ran a marathon, and MRI assessments related to cartilage health were performed at baseline and at 3 months after the marathon. The authors determined that the imaging markers of cartilage health were not different between the experimental and control groups. Although the randomized controlled trial design helped to reduce all 3 sources of bias, the small sample size and the loss to follow-up are sources of information bias, as indicated by the authors. Although randomized controlled trials are frequently categorized as Level 1 evidence, the small sample size reduced the study to a Level 2 rating. Nonetheless, these 3 excellent examples highlight the strengths and weaknesses of the different study designs and the value of including a control group to help interpret the study results.
In conclusion, readers should consider the study design and control groups when assessing the conclusions of a research article. Many factors need to be balanced when planning a study, including the question being asked, the availability of subjects, subject and investigator tolerance, the rarity of the outcome, and the resources available to the research team. Selecting a proper control group is an important consideration whether one is designing a time zero cadaveric study, a preclinical research study, or a clinical trial. Including the standard of care, a normal control group, or possibly an untreated control group could enhance many study designs. The perfect study that would eliminate bias may be as elusive as the holy grail. However, those who understand the strengths and weaknesses of the different control groups and study designs will be better able to critically read the literature.
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